Holistic versus Composite Preferences for Lifetime Treatment Sequences for Type 2 Diabetes
This study of patient preferences for lifetime treatment sequences for type 2 diabetes had three objectives: to assess the feasibility of obtaining holistic preference assess ments using the time-tradeoff (TTO) technique; to compare composite and holistic preference scores for the same lifetime trea...
Gespeichert in:
| Veröffentlicht in: | Medical decision making 1999-04, Vol.19 (2), p.113-120 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 120 |
|---|---|
| container_issue | 2 |
| container_start_page | 113 |
| container_title | Medical decision making |
| container_volume | 19 |
| creator | Mackeigan, Linda D. O'Brien, Bernie J. Oh, Paul I. |
| description | This study of patient preferences for lifetime treatment sequences for type 2 diabetes had three objectives: to assess the feasibility of obtaining holistic preference assess ments using the time-tradeoff (TTO) technique; to compare composite and holistic preference scores for the same lifetime treatment paths; and to assess the validity of composite and holistic preference measures in terms of their congruence with an in dividual's rank-order preferences. 101 persons with type 2 diabetes provided prefer ence ratings for hyperglycemic treatments lasting 30 years, including eight discrete treatment states and four treatment paths. Scenarios described drug and glucose- testing regimens, efficacy of glucose control, and side effects. After ranking and rating scenarios on a thermometer scale, subjects provided TTO preferences for each treat ment state or path scenario. Holistic assessment of treatment paths was feasible with the TTO technique, in terms of useable data (88% of interviews) and effect on coef ficients of variation. Holistic and composite preference scores were not statistically different. Agreement was poor between rankings implied by holistic and composite scores and direct rankings. The authors conclude that lifetime treatment paths with minor differences in health effects can be assessed using either composite (QALY) or holistic (HYE) measures. The validity of these TTO-based preference measures re mains unknown. Key words: individual preferences; diabetes; treatment paths; QALYs. (Med Decis Making 1999;19:113-121) |
| doi_str_mv | 10.1177/0272989X9901900201 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69734198</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0272989X9901900201</sage_id><sourcerecordid>69734198</sourcerecordid><originalsourceid>FETCH-LOGICAL-c510t-31a53f646e3b41b1146fb53bb29b335e7ea3c10a5e1d7f91e0c26539110bbb473</originalsourceid><addsrcrecordid>eNp9kEtLw0AUhQdRbH38ARcyuHAXO3cmk2SWUh8VCgpWKG7CTHojU5ImziRC_70JKVQUXN3Nd757OIRcALsBiOMJ4zFXiVoqxUAxxhkckDFIyYMogeUhGfdA0BMjcuL9mjEIVRIekxEwLoDFYkzeZ1VhfWMz-oXOt55Oq7KuvG2QvjjM0eEmQ0_zytG5zbGxJdKFQ92UuGnoK362e2CxrZFyeme1wQb9GTnKdeHxfHdPydvD_WI6C-bPj0_T23mQSWBNIEBLkUdhhMKEYADCKDdSGMOVEUJijFpkwLREWMW5AmQZj6RQAMwYE8bilFwP3tpVXR3fpKX1GRaF3mDV-jRSsQhBJR149QtcV63bdN1SzkWiooj3Nj5Amau87yZIa2dL7bYpsLSfPf07exe63JlbU-LqR2TYuQMmA-D1B-7f_qP8BqlZijU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223896627</pqid></control><display><type>article</type><title>Holistic versus Composite Preferences for Lifetime Treatment Sequences for Type 2 Diabetes</title><source>Access via SAGE</source><source>MEDLINE</source><creator>Mackeigan, Linda D. ; O'Brien, Bernie J. ; Oh, Paul I.</creator><creatorcontrib>Mackeigan, Linda D. ; O'Brien, Bernie J. ; Oh, Paul I.</creatorcontrib><description>This study of patient preferences for lifetime treatment sequences for type 2 diabetes had three objectives: to assess the feasibility of obtaining holistic preference assess ments using the time-tradeoff (TTO) technique; to compare composite and holistic preference scores for the same lifetime treatment paths; and to assess the validity of composite and holistic preference measures in terms of their congruence with an in dividual's rank-order preferences. 101 persons with type 2 diabetes provided prefer ence ratings for hyperglycemic treatments lasting 30 years, including eight discrete treatment states and four treatment paths. Scenarios described drug and glucose- testing regimens, efficacy of glucose control, and side effects. After ranking and rating scenarios on a thermometer scale, subjects provided TTO preferences for each treat ment state or path scenario. Holistic assessment of treatment paths was feasible with the TTO technique, in terms of useable data (88% of interviews) and effect on coef ficients of variation. Holistic and composite preference scores were not statistically different. Agreement was poor between rankings implied by holistic and composite scores and direct rankings. The authors conclude that lifetime treatment paths with minor differences in health effects can be assessed using either composite (QALY) or holistic (HYE) measures. The validity of these TTO-based preference measures re mains unknown. Key words: individual preferences; diabetes; treatment paths; QALYs. (Med Decis Making 1999;19:113-121)</description><identifier>ISSN: 0272-989X</identifier><identifier>EISSN: 1552-681X</identifier><identifier>DOI: 10.1177/0272989X9901900201</identifier><identifier>PMID: 10231073</identifier><identifier>CODEN: MDMADE</identifier><language>eng</language><publisher>Thousand Oaks, CA: Sage Publications</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Choice Behavior ; Cost-Benefit Analysis ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetes Mellitus, Type 2 - psychology ; Feasibility Studies ; Holistic Health ; Humans ; Hypoglycemic Agents - economics ; Hypoglycemic Agents - therapeutic use ; Middle Aged ; Patient Satisfaction ; Quality-Adjusted Life Years ; Reproducibility of Results ; Statistics, Nonparametric ; Surveys and Questionnaires ; Time Factors ; Treatment Outcome</subject><ispartof>Medical decision making, 1999-04, Vol.19 (2), p.113-120</ispartof><rights>Copyright Hanley & Belfus, Inc. Apr-Jun 1999</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c510t-31a53f646e3b41b1146fb53bb29b335e7ea3c10a5e1d7f91e0c26539110bbb473</citedby><cites>FETCH-LOGICAL-c510t-31a53f646e3b41b1146fb53bb29b335e7ea3c10a5e1d7f91e0c26539110bbb473</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/0272989X9901900201$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/0272989X9901900201$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21819,27924,27925,43621,43622</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10231073$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mackeigan, Linda D.</creatorcontrib><creatorcontrib>O'Brien, Bernie J.</creatorcontrib><creatorcontrib>Oh, Paul I.</creatorcontrib><title>Holistic versus Composite Preferences for Lifetime Treatment Sequences for Type 2 Diabetes</title><title>Medical decision making</title><addtitle>Med Decis Making</addtitle><description>This study of patient preferences for lifetime treatment sequences for type 2 diabetes had three objectives: to assess the feasibility of obtaining holistic preference assess ments using the time-tradeoff (TTO) technique; to compare composite and holistic preference scores for the same lifetime treatment paths; and to assess the validity of composite and holistic preference measures in terms of their congruence with an in dividual's rank-order preferences. 101 persons with type 2 diabetes provided prefer ence ratings for hyperglycemic treatments lasting 30 years, including eight discrete treatment states and four treatment paths. Scenarios described drug and glucose- testing regimens, efficacy of glucose control, and side effects. After ranking and rating scenarios on a thermometer scale, subjects provided TTO preferences for each treat ment state or path scenario. Holistic assessment of treatment paths was feasible with the TTO technique, in terms of useable data (88% of interviews) and effect on coef ficients of variation. Holistic and composite preference scores were not statistically different. Agreement was poor between rankings implied by holistic and composite scores and direct rankings. The authors conclude that lifetime treatment paths with minor differences in health effects can be assessed using either composite (QALY) or holistic (HYE) measures. The validity of these TTO-based preference measures re mains unknown. Key words: individual preferences; diabetes; treatment paths; QALYs. (Med Decis Making 1999;19:113-121)</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Choice Behavior</subject><subject>Cost-Benefit Analysis</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - psychology</subject><subject>Feasibility Studies</subject><subject>Holistic Health</subject><subject>Humans</subject><subject>Hypoglycemic Agents - economics</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Middle Aged</subject><subject>Patient Satisfaction</subject><subject>Quality-Adjusted Life Years</subject><subject>Reproducibility of Results</subject><subject>Statistics, Nonparametric</subject><subject>Surveys and Questionnaires</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>0272-989X</issn><issn>1552-681X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLw0AUhQdRbH38ARcyuHAXO3cmk2SWUh8VCgpWKG7CTHojU5ImziRC_70JKVQUXN3Nd757OIRcALsBiOMJ4zFXiVoqxUAxxhkckDFIyYMogeUhGfdA0BMjcuL9mjEIVRIekxEwLoDFYkzeZ1VhfWMz-oXOt55Oq7KuvG2QvjjM0eEmQ0_zytG5zbGxJdKFQ92UuGnoK362e2CxrZFyeme1wQb9GTnKdeHxfHdPydvD_WI6C-bPj0_T23mQSWBNIEBLkUdhhMKEYADCKDdSGMOVEUJijFpkwLREWMW5AmQZj6RQAMwYE8bilFwP3tpVXR3fpKX1GRaF3mDV-jRSsQhBJR149QtcV63bdN1SzkWiooj3Nj5Amau87yZIa2dL7bYpsLSfPf07exe63JlbU-LqR2TYuQMmA-D1B-7f_qP8BqlZijU</recordid><startdate>19990401</startdate><enddate>19990401</enddate><creator>Mackeigan, Linda D.</creator><creator>O'Brien, Bernie J.</creator><creator>Oh, Paul I.</creator><general>Sage Publications</general><general>SAGE PUBLICATIONS, INC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>19990401</creationdate><title>Holistic versus Composite Preferences for Lifetime Treatment Sequences for Type 2 Diabetes</title><author>Mackeigan, Linda D. ; O'Brien, Bernie J. ; Oh, Paul I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c510t-31a53f646e3b41b1146fb53bb29b335e7ea3c10a5e1d7f91e0c26539110bbb473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Choice Behavior</topic><topic>Cost-Benefit Analysis</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - psychology</topic><topic>Feasibility Studies</topic><topic>Holistic Health</topic><topic>Humans</topic><topic>Hypoglycemic Agents - economics</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Middle Aged</topic><topic>Patient Satisfaction</topic><topic>Quality-Adjusted Life Years</topic><topic>Reproducibility of Results</topic><topic>Statistics, Nonparametric</topic><topic>Surveys and Questionnaires</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mackeigan, Linda D.</creatorcontrib><creatorcontrib>O'Brien, Bernie J.</creatorcontrib><creatorcontrib>Oh, Paul I.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Medical decision making</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mackeigan, Linda D.</au><au>O'Brien, Bernie J.</au><au>Oh, Paul I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Holistic versus Composite Preferences for Lifetime Treatment Sequences for Type 2 Diabetes</atitle><jtitle>Medical decision making</jtitle><addtitle>Med Decis Making</addtitle><date>1999-04-01</date><risdate>1999</risdate><volume>19</volume><issue>2</issue><spage>113</spage><epage>120</epage><pages>113-120</pages><issn>0272-989X</issn><eissn>1552-681X</eissn><coden>MDMADE</coden><abstract>This study of patient preferences for lifetime treatment sequences for type 2 diabetes had three objectives: to assess the feasibility of obtaining holistic preference assess ments using the time-tradeoff (TTO) technique; to compare composite and holistic preference scores for the same lifetime treatment paths; and to assess the validity of composite and holistic preference measures in terms of their congruence with an in dividual's rank-order preferences. 101 persons with type 2 diabetes provided prefer ence ratings for hyperglycemic treatments lasting 30 years, including eight discrete treatment states and four treatment paths. Scenarios described drug and glucose- testing regimens, efficacy of glucose control, and side effects. After ranking and rating scenarios on a thermometer scale, subjects provided TTO preferences for each treat ment state or path scenario. Holistic assessment of treatment paths was feasible with the TTO technique, in terms of useable data (88% of interviews) and effect on coef ficients of variation. Holistic and composite preference scores were not statistically different. Agreement was poor between rankings implied by holistic and composite scores and direct rankings. The authors conclude that lifetime treatment paths with minor differences in health effects can be assessed using either composite (QALY) or holistic (HYE) measures. The validity of these TTO-based preference measures re mains unknown. Key words: individual preferences; diabetes; treatment paths; QALYs. (Med Decis Making 1999;19:113-121)</abstract><cop>Thousand Oaks, CA</cop><pub>Sage Publications</pub><pmid>10231073</pmid><doi>10.1177/0272989X9901900201</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0272-989X |
| ispartof | Medical decision making, 1999-04, Vol.19 (2), p.113-120 |
| issn | 0272-989X 1552-681X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69734198 |
| source | Access via SAGE; MEDLINE |
| subjects | Adult Aged Aged, 80 and over Choice Behavior Cost-Benefit Analysis Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - psychology Feasibility Studies Holistic Health Humans Hypoglycemic Agents - economics Hypoglycemic Agents - therapeutic use Middle Aged Patient Satisfaction Quality-Adjusted Life Years Reproducibility of Results Statistics, Nonparametric Surveys and Questionnaires Time Factors Treatment Outcome |
| title | Holistic versus Composite Preferences for Lifetime Treatment Sequences for Type 2 Diabetes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T17%3A29%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Holistic%20versus%20Composite%20Preferences%20for%20Lifetime%20Treatment%20Sequences%20for%20Type%202%20Diabetes&rft.jtitle=Medical%20decision%20making&rft.au=Mackeigan,%20Linda%20D.&rft.date=1999-04-01&rft.volume=19&rft.issue=2&rft.spage=113&rft.epage=120&rft.pages=113-120&rft.issn=0272-989X&rft.eissn=1552-681X&rft.coden=MDMADE&rft_id=info:doi/10.1177/0272989X9901900201&rft_dat=%3Cproquest_cross%3E69734198%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223896627&rft_id=info:pmid/10231073&rft_sage_id=10.1177_0272989X9901900201&rfr_iscdi=true |